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ABSTRACT 
 
The article presents the results of studying the interaction of polymorphic variants of vascular 
homeostasis genes (I/D ACE, 4а/4b eNOS, S311C PON2, (-6) A/G AGT, (-1166) A/С AGTR1, G/A GNB3 
(rs.2301339), G460W ADD1, (+46) G/A ADRB2, K198N EDN1, (+6986) G/A CYP3A5) with the state of renal 
function at the onset of chronic glomerulonephritis. The factors, reducing the risk of decrease in kidneys 
function, in patients with chronic glomerulonephritis, at the onset of the disease, were found (311S allele and 
genotype 311SS PON2, OR = 2.14 and 2.60 respectively). The protective factors for renal dysfunction 
development at the onset of disease are 311C PON2 allele and genotypes 311SC PON2, -1166AC AGTR1 (OR = 
0.47; 0.42 and 0.17 respectively). 
Keywords: chronic glomerulonephritis, genetic polymorphism, genes of vascular homeostasis, preserved and 
reduced kidney function. 
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INTRODUCTION 
 
Chronic glomerulonephritis (CGN) – is a group of diseases of different origin and morphological 
manifestations. Chronic glomerulonephritis is characterized by genetically determined immune-mediated 
inflammation of the renal glomeruli, which may be accompanied by involvement of all renal structures in 
pathological process (Litovkina et al, 2014a; Gao et al, 2016), by the development of renal failure, renal 
scarring, arterial hypertension, as well as it can lead to death from chronic renal failure (Litovkina et al., 
2014b). 
 
The leading direction of modern nephrology development is the molecular genetic study of 
endogenous/genetic factors, which cause the disease. One of such promising approaches, in the study of 
genetic susceptibility to the disease, is the use of so-called candidate genes (Westland et al, 2015; Westland et 
al, 2015). As candidate genes, whose expression products can determine the rate of progression of renal 
disease, first of all are considered the genes of vascular homeostasis, which regulate hemodynamic processes, 
as well as the processes of synthesis and degradation of extracellular matrix and affect the rate of 
glomerulosclerosis development (Litovkina et al., 2014a; Gao et al, 2016). It should be noted, that the results 
of works, dedicated to the study of vascular homeostasis polymorphisms involvement in the formation, 
development and progression of chronic glomerulonephritis, are inconsistent in different populations of the 
world, and in the Russian Federation such studies are also few. 
 
MATERIALS AND METHODS 
 
Two samples were formed for carrying out the study. The control group consisted of 304 persons; the 
group of patients with chronic glomerulonephritis included 238 individuals. The sample data consisted of 
Russian citizens of Central Black Earth region of Russia, with no family ties between them. The patients were 
included in the group of medical cases only after making the disease diagnosis, confirmed by clinical and 
laboratory instrumental methods of examination on the basis of Nephrology Department of the Belgorod 
Regional Hospital. The exclusion criteria for the group of patients with chronic glomerulonephritis were 
diabetes (in history or revealed in the process of examination), hypertension. 
 
In the group of patients with chronic glomerulonephritis and in the control group, it was carried out 
the genotyping of ten polymorphic markers of vascular homeostasis - angiotensin-converting enzyme (I/D 
ACE), endothelial synthase of nitric oxide (4a/4b eNOS), paraoxonase-2 (C311S PON2), angiotensinogen ((-6 ) 
A/G AGT), angiotensin-II receptor of the first type ((-1166) A/C ATGTR1), β3-subunits of the guanine binding 
protein (G/A GNB3 rs.2301339), α-adducin (G460W ADD1), β2- adrenoreceptor ((+46) G/A ADRB2), 
endothelin-1 (K198N EDN1), cytochrome 3A5 ((+6989) A/G CYP3A5). 
 
The venous blood in the amount of 8-9 ml, taken from the cubital vein of proband, was the material 
for the study. The isolation of genomic DNA from peripheral blood was conducted by the method of phenol-
chloroform extraction of Miller S.A. et al. (1988). The molecular genetic analysis of all loci was carried by the 
method of polymerase chain reaction of DNA synthesis, using oligonucleotide primers and probes. (Agerholm-
Larsen et al., 2000; Asai et al., 2001; Jalilian et al., 2008; Lanfear et al., 2005; Picard et al., 2007; Prasad et al., 
2006; Yazdanpanah et al., 2007). 
 
The analyses of alleles and genotypes associations of studied DNA markers with renal function in 
patients with chronic glomerulonephritis was carried out using the analysis of 2x2 contingency tables, with 
calculation of criterion 2, with Yates correction for continuity and odds ratios (OR) with 95% confidence 
intervals (CI). In the process of carrying out the multiple comparisons, in order to minimize the errors of the 1st 
kind, connected with obtaining false positive results, the Bonferroni correction was used (pcor). 
 
RESULTS 
 
238 patients with chronic glomerulonephritis and 304 people from the control group were examined. 
The main characteristics of the study group of patients with chronic glomerulonephritis and the group of 
population control are shown in Table 1. 
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Table1. Characteristics of the subjects from the case and control groups 
Characteristics Cases Controls 
Total 238 304 
Males 53.4% 53.9% 
Female 46.6% 46.1% 
Age, yrs 39.58 ±14.58 42.20 ± 6.28 
Weight, kg 63.4 ± 2.1 67.4 ± 1.7 
Height, cm 165.4 ± 3.4 168.6 ± 2.7 
SBP, mm Hg 148.4 ± 26.5 128.1 ± 4.4 
DBP, mm Hg 92.7 ± 14.0 82.2 ± 2.0 
 
The control group is fully comparable with the sample of patients with chronic glomerulonephritis, 
according to given characteristics (p> 0.05). 
 
To assess kidney function at the onset of the disease, the following two groups were formed: the first 
group consisted of patients with preserved function (n = 107 individuals), the second group consisted of 
patients with decrease in kidney function, they had excessive level of creatinine (more than 140 mcM/l) (n = 55 
individuals). 
 
In the process of the study of polymorphic genetic markers distribution among the patients with 
chronic glomerulonephritis with preserved and reduced kidney function, as well as in the control group, it was 
found statistically significant differences in frequencies of genotypes and alleles in locus S311C of 
paraoxonase-2. It was defined, that among the patients with chronic glomerulonephritis with reduced kidney 
function, the concentration of genotype 311SS was 72.72% and it was the highest, compared as to the control 
group, where this index was 50.66% (χ2 = 8.27, p = 0.005, taking into account the Bonferroni correction pcor = 
0.015, OR = 2.60, 95% Cl 1.32-5.15), as to the patients with chronic glomerulonephritis with preserved renal 
function (52.83%, χ2 = 5.16, p = 0.02, pcor = 0.06). The differences in the prevalence of genotype 311SC PON2 
between the patients with reduced renal function, and the control group were defined: among the patients, 
the concentration of the marker was more than 1.7 times lower than in the control group (χ2 = 6.12, p = 0.01, 
pcor = 0.03, OR = 0.42, 95% Cl 0.21-0.85). 
 
According to the distribution of alleles of the locus S311C PON2, the following results were obtained: 
higher frequency of allele 311S is in patients with reduced renal function (84.55%), compared as to the group 
of patients with preserved renal function (72.17%, χ2 = 5.48, p = 0.02 ) as to the control group (71.88%, χ2 = 
7.10, p = 0.009, oR = 2.14, 95% Cl 1.20-3.84). 
 
As for the locus (-1166) A/C AGTR1, significant differences in genotypes concentrations among the 
patients with chronic glomerulonephritis with preserved and reduced kidney function, were also obtained. 
Thus, in patients with reduced renal function, the frequency of genotype      (-1166) AC equaled 28.85%, that 
was significantly lower (1.7 times) compared to the concentration of given genotype among patients with 
preserved renal function (50.47%, χ2 = 5.81 p = 0.017, pcor = 0.05). 
 
DISCUSSION 
 
 Molecular genetic markers, which are the risk factors for decreased renal function in patients at the 
onset of chronic glomerulonephritis (311S and 311SS PON2, OR = 2.14 and 2.60), and protective factors - allele 
311C PON2 and genotypes 311SC PON2, (- 1166) AC AGTR1 (OR = 0.47; 0.42 and 0.17, respectively) were 
defined in our research. 
 
 It should be noted, that in the literature, the information about the interaction of polymorphism 
S311C PON2 with renal function in patients with nephropathy is few. Today, the considerable number of facts 
is collected; they showing that an important pathogenetic link in the development of glomerulonephritis is the 
imbalance in the functioning of the lipid peroxidation and antioxidant protection system (Sawant et al, 2010; 
Litovkina et al, 2014b). The damage of the kidney structures may begin with the formation of reactive oxygen 
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intermediates, stimulated by neutrophils, macrophages and mesangial cells of renal glomeruli. If the 
antioxidant defense system becomes untenable, it may lead to enchancement of lipid peroxidation and 
membranes damage of nephrothelial cells. One of the main enzymes, preventing lipid peroxidation, is 
paraoxonase. The production decrease of this enzyme reduces the reserves of antioxidant defense, facilitates 
the progression of glomerulosclerosis and renal function decrease (Litovkina et al., 2014b). 
 
 In the available literature, there is the evidences on the interaction of polymorphism     (-1166) A/C 
AGTR1 with various renal pathologies (Jacobsen et al, 2003; Buraczynska et al, 2006). So in the work 
(Buraczynska et al., 2006) in the process of study of the renin-angiotensin system genes, it was found that the 
genotype (-1166) CC of angiotensin II receptor type 1 gene, was more frequent in patients with interstitial 
nephritis. It was found that patients with allele      (-1166) C, the average time of the disease development to 
end-stage of renal failure was significantly less than in individuals with genotype (-1166) AA of AGTR1 locus. In 
the study (Jacobsen P. et al., 2003), it found the interaction of allele (-1166C) of AGTR1 locus with the 
development of diabetic nephropathy. 
 
 The connection of polymorphism (-1166) A/C AGTR1 with renal function state can be explained in 
such a way. The polymorphism of AGTR1 gene, localized in the 3'- non-translating region of the gene, results 
the substitution in 1166 the position of adenine to cytosine (rs.5186). It has been found, that such replacement 
modifies the structure of gene’s regulatory cis-element, that leads to increase of its expression (Wang et al, 
2006; Sethupathy et al, 2007.). 
 
CONCLUSION 
 
In the course of our study, the polymorphic genetic markers 311S and 311SS PON2, which are the risk 
factors for decreased renal function in patients with chronic glomerulonephritis in the onset of the disease (OR 
= 2,14 and 2,60 respectively) were defined. The allele 311C PON2 and genotypes 311SC PON2, (-1166) AC 
AGTR1 can be considered as protective factors for renal dysfunction development at the onset of the disease 
(OR = 0,47; 0,42 and 0,17 respectively). 
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